News– category –
-
nonat Inc. Obtained a Medical Device Manufacturing License
We are pleased to announce that nonat Inc. has obtained a Medical Device Manufacturing License. We have been developing foundation models for medical AI and ... -
nonat Inc. Raises 130 Million JPY (Approx. USD 0.9 Million) in Pre-Series A Funding
nonat Inc. (Gifu, Japan; CEO: Keisuke Ito) is pleased to announce that we have raised 130 million JPY (approximately USD 0.9 million) in our Pre-Series A fun... -
Selected for the Startup Support Program by the Japanese Ministry of Internal Affairs and Communications
We are pleased to announce that nonat Inc. has been selected for the FY2025 “ICT Startup League,” a startup support program organized by Japan’s Ministry of ... -
Commencement of the Third Clinical Research
On January 8, 2025, nonat Inc. received approval from the Gifu University Graduate School of Medicine’s Research Ethics Committee for Medical Research and ha... -
Presenting First Clinical Research Findings at the 77th Annual Congress of the Japan Society of Obstetrics and Gynecology
We are pleased to announce that we will be presenting at the 77th Annual Congress of the Japan Society of Obstetrics and Gynecology, scheduled to be held in ... -
Completed an Application for Ethical Review for a Third Clinical Research
We are pleased to announce that nonat Inc. has submitted an ethics review for the third round of clinical research. This study builds upon the remarkable fin... -
Commencement of the Second Clinical Research
We are pleased to announce that nonat Inc. has received approval from the Ethics Review Committee of the Graduate School of Medicine, Gifu University, to com... -
Notification of Setting the Record Date
Notification of Setting the Record Date We hereby announce that June 28, 2024, has been set as the record date, and shareholders listed in the shareholders' ... -
Completed an Application for Ethical Review for a Second Clinical Research
nonat Inc. has applied for an ethical review of its second clinical study, following the promising results from the first clinical study. This study is expec... -
We are applying for an ethical review on November 16, 2023.
We are currently applying for an ethical review based on our business plan. We plan to continuously update our progress, anticipating future academic present...
12